buprenorphine 96 MG per 0.27 ML extended release Prefilled Syringe
- RxCUI
- 2639041
- RxNorm name
- buprenorphine 96 MG per 0.27 ML extended release Prefilled Syringe
- Display name
- buprenorphine 96 MG per 0.27 ML extended release Prefilled Syringe
- Full name
- buprenorphine 96 MG per 0.27 ML extended release Prefilled Syringe
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BRIXADI | BUPRENORPHINE | Braeburn Inc. | 5d8a8fd0-8619-422a-a664-d1d2e8970f48 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 2639041 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5d8a8fd0-8619-422a-a664-d1d2e8970f48 | buprenorphine 96 MG in 0.27 ML Monthly Extended Release Prefilled Syringe [PSN] · 0.27 ML buprenorphine 356 MG/ML Prefilled Syringe [SCD] · buprenorphine 96 MG per 0.27 ML extended release Prefilled Syringe [SY] | 3 | 6 | These highlights do not include all the information needed to use BRIXADI safely and effectively. See full prescribing information for BRIXADI. BRIXADI ® (buprenorphine) extended-release injection for subcutaneous use CIII Initial U.S. Approval: 2002 | 20251231 |